Canario, Norma T.

HRN: 06-06-48  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/23/2023
CLOXACILLIN 250MG/5ML, 60ML SUSPENSION (BOT)
02/23/2023
03/01/2023
IV
600mg
TID
Non-healing Wound; UTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary TractPneumonia    Compliance to guidelines: Non-compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: